# Qilu Pharmaceutical (Hainan) Co. Ltd. – FDA Inspection, May 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/6e8bd43e-ed93-47e5-874e-e0800b7e48d1
Source feed: FDA_Inspections

> FDA inspection 1209088 of Qilu Pharmaceutical (Hainan) Co. Ltd., May 19, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209088
- Company Name: Qilu Pharmaceutical (Hainan) Co. Ltd.
- Inspection Date: 2023-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1281926 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/767c8add-29d3-4bb2-aa95-0b733a0ece90)
- [FDA Inspection 1111054 - 2019-11-06](https://www.keypedia.com/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/82214876-7e78-4952-b51e-a5128b2e1651)
- FDA Inspection 1036684 - 2017-11-17
- FDA Inspection 984197 - 2016-08-02
- FDA Inspection 880306 - 2014-05-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)
- [FDA Associated Person](https://www.keypedia.com/people/suzanne-n-vallez/7c16e0f4-c0b1-4f50-adfa-b1dc534694cd)

Company: https://www.keypedia.com/companies/qilu-pharmaceutical-hainan-co-ltd/60dedaab-e32c-493a-894b-9eec7372c066

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
